| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2022 | Apr 25, 2022 | Pyxis Oncology, Inc. | Other | Sell | 16.3 | -1,745,761 | -100.00% | ✗ | $5.3M |
| Oct 13, 2021 | Oct 15, 2021 | Pyxis Oncology, Inc. | Director | Buy | 100.0 | +312,500 | 21.80% | ✗ | $5M |
| Jul 16, 2021 | Jul 28, 2021 | Enliven Therapeutics, Inc. | Director | Buy | 100.0 | +1,333,333 | 131.92% | ✗ | $8M |
| Mar 16, 2020 | Mar 16, 2020 | Enliven Therapeutics, Inc. | Director | Buy | 100.0 | +187,500 | 13.72% | ✗ | $3M |
| Oct 30, 2018 | Nov 1, 2018 | Iterum Therapeutics plc | Director | Buy | 92.5 | +58,000 | 5.62% | ✗ | $353.8K |
| May 30, 2018 | Jun 1, 2018 | Iterum Therapeutics plc | Director | Buy | 100.0 | +337,606 | 48.63% | ✗ | $4.4M |